396 resources
Prev Rows 200 - 396
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-leg-org | CH ELM Results Leg Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-lis-org | CH ELM Results Lis Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-mal-org | CH ELM Results Mal Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-maldi-tof-org | CH ELM Results Maldi-tof Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-mea-org | CH ELM Results Mea Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-men-org | CH ELM Results Men Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpox-org | CH ELM Results Mpox Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpx-ctng | CH ELM Results Mpx Ctng | active | 2025-06 | hl7 | |||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpx-sash | CH ELM Results Mpx Sash | active | 2025-06 | hl7 | |||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpx-sashec | CH ELM Results Mpx Sashec | active | 2025-06 | hl7 | |||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-pneu-org | CH ELM Results Pneu Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-sal-org-complete | CH ELM Results Sal Org Complete | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-sal-org | CH ELM Results Sal Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-shi-org | CH ELM Results Shi Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-sterile-spec | CH ELM Results Sterile Spec | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-tub-gen-org | CH ELM Results Tub Gen Org | active | 2025-06 | hl7 | |||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-tub-org | CH ELM Results Tub Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-tub-spec | CH ELM Results Tub Spec | active | 2025-06 | hl7 | |||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-tul-org | CH ELM Results Tul Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-virus-cult-org | CH ELM Results Virus Cult Org | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-component-antibiotic-tb | CH ELM Results Antibiotic Tb | active | 2025-06 | hl7 | loinc | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-dssplus | NKRS - DSSplus | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-pretextstaging | NKRS - PRETEXT Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-torontotierIImanualstaging | NKRS - Toronto Tier II (Manual) Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-immunization-allergyintolerances-vs | Allergies and Intolerance values for Immunization | draft | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-circumferentialresectionmargins | NKRS - Circumferential Resection Margins | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-basic-immunization-vs | Basic Immunization Codes | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-entry-conflict-vs | Entry Conflict Codes | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-icdo3histologicalgrade | NKRS - ICD-O-3 Histological Grade | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-topographymetastases | NKRS - Topography of Metastases | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-lymphaticinvasion | NKRS - Lymphatic Invasion | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-venousinvasion | NKRS - Venous Invasion | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-sentinellymphnodeassessment | NKRS - Sentinel Lymph Node Assessment | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-luganostaging | NKRS - Lugano Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-diagnosticmethodsused | NKRS - Diagnostic Methods Used | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-cn | NKRS - cN | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-her2receptorstatus | NKRS - Her2 Receptor Status | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-issstaging | NKRS - ISS Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-stjudemurphystaging | NKRS - St. Jude / Murphy Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-serumtumourmarkers | NKRS - Serum Tumour Markers | active | 2022-02 | hl7 | internal sct | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-tnmstagegroup | NKRS - TNM Stage Group | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-pn | NKRS - pN | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-cm | NKRS - cM | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-pm | NKRS - pM | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-hcg | NKRS - β-hCG | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-ldh | NKRS - LDH | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-methodfirstdetection | NKRS - Method of First Detection | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-diabetesmellitus | NKRS - Diabetes Mellitus | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-liverdisease | NKRS - Liver Disease | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-alphafetoprotein | NKRS - α-fetoprotein | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-typerecurrencetransformation | NKRS - Type of Recurrence/Transformation | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-msuffixofpt | NKRS - m-Suffix of pT | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-ct | NKRS - cT | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-treatmentgoal | NKRS - Treatment Goal | active | 2022-02 | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-swissmedic-imunglobuline-vs | CH VACD Swissmedic Authorized Immunglobuline Codes | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-swissmedic-imunsera-vs | CH VACD Swissmedic Authorized Immunsera Codes | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-vaccines-snomedct-vs | CH VACD Snomed CT for VaccineCode | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-vaccines-vs | CH VACD Swissmedic code for VaccineCode | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | snomedct-concept-viraldiseases-vs | Snomed CT Concept Viral Diseases | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-vs | Swiss Risks For Immunizations | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-medical-vs | Swiss Medical Risks For Immunizations | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-occupation-vs | Swiss Occupation Risks For Immunizations | active | 2025-05 | hl7 | internal sct | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-irssstaging | NKRS - IRSS Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-preillness-vs | Swiss Preillness Risks For Immunizations | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-route-of-administration-vs | CH VACD Route of Administration for Immunization | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-social-vs | Swiss Social Risks For Immunizations | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-foph-patient-name-representation | CH ELM FOPH Patient Name Representation | active | 2025-06 | hl7 | internal | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-avidity | CH ELM Interpretation Codes AVIDITY | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-pos-neg | CH ELM Interpretation Codes Positive and Negative | active | 2025-06 | hl7 | tho | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-pos | CH ELM Interpretation Codes Positive | active | 2025-06 | hl7 | tho | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-res-sus | CH ELM Interpretation Codes Resistant and Susceptible | active | 2025-06 | hl7 | tho | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-res | CH ELM Interpretation Codes Resistant | active | 2025-06 | hl7 | tho | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-sero | CH ELM Interpretation Codes SERO | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-titer | CH ELM Interpretation Codes TITER | active | 2025-06 | hl7 | tho | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation-complete | CH ELM Results Laboratory Observation Complete | active | 2025-06 | hl7 | sct loinc | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation-susc | CH ELM Results Laboratory Observation Susceptibility | active | 2025-06 | hl7 | loinc | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation-geno | CH ELM Results Laboratory Observation Genotyping | active | 2025-06 | hl7 | loinc | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-status | CH ELM Status | active | 2025-06 | hl7 | fhir | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-lab-study-types | CH ELM Lab Study Types | active | 2025-06 | hl7 | sct loinc | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation | CH ELM Results Laboratory Observation | active | 2025-06 | hl7 | sct loinc | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-coded-values-laboratory | CH ELM Results Coded Values Laboratory | active | 2025-06 | hl7 | sct | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-expecting-organism-specification | CH ELM Expecting Organism Specification | active | 2025-06 | hl7 | loinc | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-expecting-specimen-specification | CH ELM Expecting Specimen Specification | active | 2025-06 | hl7 | loinc | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-observation-profile-vs | CH ELM Observation Profile Vs | active | 2025-06 | hl7 | internal | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-completion-vs | CH ELM Results Completion Vs | active | 2025-06 | hl7 | internal | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-results-component-vs | CH ELM Results Component Vs | active | 2025-06 | hl7 | internal | ||
| ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-vs | CH ELM Interpretation Codes Vs | active | 2025-06 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-raistaging | NKRS - Rai Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-annarborstaging | NKRS - Ann Arbor Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-iccc3code | NKRS - ICCC-3 Code | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-iccc3extendedcode | NKRS - ICCC-3 Extended Code | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-creasmangradingsystem | NKRS - Creasman Grading System | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-siopstaging | NKRS - SIOP Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-cogstaging | NKRS - COG Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-basisoffirsttreatmentcomplexdecision | NKRS - Basis of First Treatment Complex Decision | active | 2022-02 | hl7 | internal tho | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-icdo3behaviour | NKRS - ICD-O-3 Behaviour | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-pt | NKRS - pT | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-shimadagradingsystem | NKRS - Shimada Grading System | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-elstonellisgradingsystem | NKRS - Elston/Ellis Grading System | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-salzerkuntschikgradingsystem | NKRS - SalzerKuntschik Grading System | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-iccc3maingroup | NKRS - ICCC-3 Main Group | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-inrgssstaging | NKRS - INRGSS Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-binetstaging | NKRS - Binet Staging | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-residualinsitutumour | NKRS - Residual In-situ Tumour | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-residualinvasivetumour | NKRS - Residual Invasive Tumour | active | 2022-02 | hl7 | internal | ||
| ch.fhir.ig.ch-term | R4 | ch-core-encounter-participation-type | ChCoreEncounterParticipationType | active | 2020-04 | hl7 | fhir tho | ||
| ch.fhir.ig.ch-epreg | R4 | fetal-rhd-antigen | CH EPREG VS: Fetal RhD Antigen | active | 2025-05 | hl7 | loinc | ||
| ch.fhir.ig.ch-epreg | R4 | blood-group | CH EPREG VS: Blood Group | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-epreg | R4 | fetal-position | CH EPREG VS: Fetal Position | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-epreg | R4 | parent | CH EPREG VS: Parent | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-specialty | Swissnoso Specialty | active | 2022-06 | hl7 | internal | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-organizational-unit | Swissnoso Organizational Unit | active | 2022-06 | hl7 | internal | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-germ | Swissnoso Germ | active | 2022-06 | hl7 | sct | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-bacterial-count-in-urine | Swissnoso Bacterial Count in Urine | active | 2022-06 | hl7 | internal | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-clinical-symptom | Swissnoso Clinical Symptom | active | 2022-06 | hl7 | internal | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-indication | Swissnoso Indication | active | 2022-06 | hl7 | internal | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-number-of-different-germs | Swissnoso Number of Different Germs | active | 2022-06 | hl7 | internal | ||
| ch.fhir.ig.swissnoso | R4 | swissnoso-procedure-location | Swissnoso Procedure Location | active | 2022-06 | hl7 | internal | ||
| ch.fhir.ig.ch-lab-report | R4 | ch-lab-bloodgroup-immuno-hematology-vs | CH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures) | draft | 2024-05 | hl7 | sct | ||
| ch.fhir.ig.ch-lab-report | R4 | ch-lab-bloodgroup-antibody-vs | CH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances) | active | 2024-05 | hl7 | sct | ||
| ch.fhir.ig.ch-lab-report | R4 | ch-lab-bloodgroup-antibody-screen-vs | CH LAB-Report BloodGroup Antibody Screen Test (LOINC codes) | draft | 2024-05 | hl7 | loinc | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs | CH VACD Target disease and illnesses undergone for immunization | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | DocumentEntry.typeCode | DocumentEntry.typeCode | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-epr-term | R4 | DocumentEntry.typeCode | DocumentEntry.typeCode | active | 2023-12 | hl7 | sct | ||
| ch.fhir.ig.ch-epr-term | R4 | DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode | active | 2023-12 | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-amount-quantity-unit-code | Amount Quantity Unit Codes | draft | 2025-01 | hl7 | ucum sct | ||
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-time-quantity-unit-code | Time Quantity Unit Codes | draft | 2025-01 | hl7 | ucum | ||
| ch.fhir.ig.ch-term | R4 | UnitCode | UnitCode | active | 2025-05 | hl7 | ucum sct | ||
| ch.fhir.ig.ch-epl | R5 | ch-authorisation-type | CH - Authorisation Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-appointmentstatus | Appointment Status | active | 2025-05 | hl7 | fhir | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-consentstatus | Consent Status | active | 2025-05 | hl7 | internal sct | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-coverageidentifiertype | Coverage Identifier Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-desiredaccommodation | Desired Accomodation | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-encounterclass | Encounter Class | active | 2025-05 | hl7 | tho | ||
| ch.fhir.ig.ch-epr-fhir | R4 | PpqmConsentIdentifierType | CH PPQm Consent Identifier Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-legalrelation | Legal Relation | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-limitationstatus | CH EPL - Limitation Status | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-listing-status | CH EPL - Listing Status | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-other-characteristics-type | CH - Other Characteristics Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-other-characteristics-packaged-item | CH EPL - Other Characteristics Packaged Item | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epr-ppqm | R4 | PpqmConsentIdentifierType | PPQm Consent Identifier Type | active | 2023-12 | hl7 | internal | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-personalrelation | Personal Relation | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-pricetype | CH EPL - Price Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-reimbursement-status | CH EPL - Reimbursement Status | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-type-of-price-change | CH EPL - Type of Price Change | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-additional-monitoring-indicator | CH SMC- Additional Monitoring Indicator | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-authorisation-category | CH SMC - Authorisation Category | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-authorisation-status | CH SMC - Authorisation Status | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-authorised-pharmaceutical-dose-form | CH SMC - Authorised Pharmaceutical Dose Form | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | edqm-combination-packaging | EDQM - Combination Packaging | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | edqm-combined-pharmaceutical-dose-form | EDQM - Combined Pharmaceutical Dose Form | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | edqm-combined-term | EDQM - Combined Term | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | ema-domain | EMA - Domain | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-gamme | CH EPL - Gamme | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-ingredient-role | CH SMC - Ingredient Role | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ema-intended-effect | EMA - Intended Effect | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-attached-document-type | CH SMC - Attached Document Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-legal-status-of-supply | CH SMC - Legal Status of Supply | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-marketing-status | CH SMC - Marketing Status | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-medicinal-product-name-type | CH - Medicinal Product Name Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | edqm-packaging | EDQM - Packaging | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-pediatric-use-indicator | CH SMC - Pediatric Use Indicator | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | edqm-pharmaceutical-dose-form | EDQM - Pharmaceutical Dose Form | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-product-type | CH EPL - Product Type | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | edqm-route-of-administration | EDQM - Route Of Administration | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | ema-shelf-life-type | EMA - Shelf Life Type | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-special-precautions-for-storage | CH SMC - Special Precautions for Storage | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-substance | CH SMC - Substance | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-therapeuticproductcode | CH SMC - TherapeuticProductcode | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-epl | R5 | edqm-unit-of-presentation | EDQM - Unit of Presentation | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-epr-fhir | R4 | restricted-http-verb-vs | Restricted HTTP Verb Value Set | active | 2025-05 | hl7 | fhir | ||
| ch.fhir.ig.ch-term | R4 | treatmentreason | Treatment Reason | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | edqm-administrationmethod | EDQM - Administration Method | active | 2025-05 | hl7 | oid | ||
| ch.fhir.ig.ch-lab-report | R4 | observation-code-entsvol-ratio | CH LAB-Report Codes for Erythrocyte Distribuiton Width Test | draft | 2025-05 | hl7 | loinc | ||
| ch.fhir.ig.ch-lab-report | R4 | observation-code-mdrd-male-female | CH LAB-Report Codes for eGFR (MDRD) | draft | 2025-05 | hl7 | loinc | ||
| ch.fhir.ig.ch-lab-report | R4 | observation-code-cdk-epi-2009 | CH LAB-Report Codes for eGFR in CKD-EPI | draft | 2025-05 | hl7 | loinc | ||
| ch.fhir.ig.ch-lab-report | R4 | observation-code-cdk-epi-2021 | CH LAB-Report Codes for eGFR in CKD-EPI 2021 | draft | 2025-05 | hl7 | loinc | ||
| ch.fhir.ig.ch-term | R4 | edqm-pharmaceuticaldoseform | EDQM - Pharmaceutical Dose Form | active | 2025-05 | hl7 | oid | ||
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-route-of-administration | Route of Administration | draft | 2025-01 | hl7 | oid | ||
| ch.fhir.ig.ch-term | R4 | edqm-routeofadministration | EDQM - RouteOfAdministration | active | 2025-05 | hl7 | oid | ||
| ch.fhir.ig.ch-lab-order | R4 | MicrobiolProcedures | Microbiological Procedure | active | 2025-05 | hl7 | sct | ||
| ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-acquisition-modality | Modality that created the series | active | 2025-05 | hl7 | internal | ||
| ch.fhir.ig.ch-lab-order | R4 | ServiceRequest.categories | Service Request Categories for Questionnaires | active | 2021-06 | hl7 | internal | ||
| ch.fhir.ig.ch-term | R4 | ech-7-cantonflabbreviation | eCH-0007 Canton Abbreviation incl. FL (Fürstentum Liechtenstein) | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-7-cantonabbreviation | eCH-0007 Canton Abbreviation | active | 2025-05 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-46-emailcategory | eCH-0046 Email Category | active | 2023-03 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-46-internetcategory | eCH-0046 Internet Category | active | 2023-03 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-46-phonecategory | eCH-0046 Phone Category | active | 2023-03 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-10-linetype | eCH-010 Address Line Type | active | 2018-11 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-11-namedatatype | eCH-011 NameDataTypes | active | 2018-11 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-11-firstnamedatatype | eCH-011 FirstNameDataTypes | active | 2018-11 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-11-maritaldata-separation | eCH-011 MaritalData Separation | active | 2020-10 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-11-maritalstatus | eCH-011 MaritalStatus | active | 2018-11 | hl7 | |||
| ch.fhir.ig.ch-term | R4 | ech-11-sex | eCH-011 Sex | active | 2018-11 | hl7 | |||
| ch.fhir.ig.ch-lab-order | R4 | ch-lab-order-study-types | Laboratory Study Types | active | 2025-05 | hl7 | loinc |
FHIR